Androsova, Ganna, Krause, Roland, Borghei, Mojgansadat, Wassenaar, Merel, Auce, Pauls, Avbersek, Andreja, Becker, Felicitas, Berghuis, Bianca, Campbell, Ellen, Coppola, Antonietta et al (show 15 more authors)
(2017)
Comparative effectiveness of antiepileptic drugs in patients with mesial temporal lobe epilepsy with hippocampal sclerosis.
EPILEPSIA, 58 (10).
pp. 1734-1741.
![]() |
Text
EpiPGX MTLE-HS manuscript Epilepsia 2017.docx - Author Accepted Manuscript Download (118kB) |
Abstract
<h4>Objective</h4>Mesial temporal lobe epilepsy with hippocampal sclerosis (MTLE-HS) is a common epilepsy syndrome that is often poorly controlled by antiepileptic drug (AED) treatment. Comparative AED effectiveness studies in this condition are lacking. We report retention, efficacy, and tolerability in a cohort of patients with MTLE-HS.<h4>Methods</h4>Clinical data were collected from a European database of patients with epilepsy. We estimated retention, 12-month seizure freedom, and adverse drug reaction (ADR) rates for the 10 most commonly used AEDs in patients with MTLE-HS.<h4>Results</h4>Seven hundred sixty-seven patients with a total of 3,249 AED trials were included. The highest 12-month retention rates were observed with carbamazepine (85.9%), valproate (85%), and clobazam (79%). Twelve-month seizure freedom rates varied from 1.2% for gabapentin and vigabatrin to 11% for carbamazepine. Response rates were highest for AEDs that were prescribed as initial treatment and lowest for AEDs that were used in a third or higher instance. ADRs were reported in 47.6% of patients, with the highest rates observed with oxcarbazepine (35.7%), topiramate (30.9%), and pregabalin (27.4%), and the lowest rates with clobazam (6.5%), gabapentin (8.9%), and lamotrigine (16.6%). The most commonly reported ADRs were lethargy and drowsiness, dizziness, vertigo and ataxia, and blurred vision and diplopia.<h4>Significance</h4>Our results did not demonstrate any clear advantage of newer versus older AEDs. Our results provide useful insights into AED retention, efficacy, and ADR rates in patients with MTLE-HS.
Item Type: | Article |
---|---|
Uncontrolled Keywords: | Retention, Efficacy, Adverse drug reactions, Drug response, Seizure freedom |
Depositing User: | Symplectic Admin |
Date Deposited: | 11 Sep 2017 06:36 |
Last Modified: | 19 Jan 2023 06:55 |
DOI: | 10.1111/epi.13871 |
Related URLs: | |
URI: | https://livrepository.liverpool.ac.uk/id/eprint/3009369 |